(Q35600006)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14654794%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

review article

1 reference

title

Paediatric clinical trials: redressing the imbalance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14654794%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14654794%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Mark S Schreiner

series ordinal

1

1 reference

9 August 2017

publication date

1 December 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14654794%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Drug Discovery

21 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14654794%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14654794%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14654794%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

949-961

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14654794%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrd1253

21 December 2019

exact match

0 references

1 reference

Pharmacokinetic and pharmacodynamic data collection in children and neonates. A quiet frontier

31 March 2020

1 reference

Paediatric labelling requirements. Implications for pharmacokinetic studies

31 March 2020

1 reference

Paediatric prescribing: using unlicensed drugs and medicines outside their licensed indications

31 March 2020

1 reference

Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children

31 March 2020

1 reference

Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands

31 March 2020

1 reference

A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital

31 March 2020

1 reference

Unlicensed and off-label drug use in an Australian neonatal intensive care unit

31 March 2020

1 reference

Off label prescribing to children in primary care in Germany: retrospective cohort study

31 March 2020

1 reference

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

31 March 2020

1 reference

Medication errors and adverse drug events in pediatric inpatients

31 March 2020

1 reference

Adverse drug reactions and off-label drug use in paediatric outpatients

31 March 2020

1 reference

Off label use--label off use?

31 March 2020

1 reference

Pediatric drug labeling: improving the safety and efficacy of pediatric therapies

31 March 2020

1 reference

Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis

31 March 2020

1 reference

Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect".

31 March 2020

1 reference

Do sick newborn infants benefit from participation in a randomized clinical trial?

31 March 2020

1 reference

The "inclusion benefit" in clinical trials

31 March 2020

1 reference

Testing medications in children.

31 March 2020

1 reference

Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products

31 March 2020

1 reference

Balancing moral principles in federal regulations on human research.

31 March 2020

1 reference

Withholding proven treatment in clinical research

31 March 2020

1 reference

Current issues in clinical trial design: superiority versus equivalency studies

31 March 2020

1 reference

Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues

31 March 2020

1 reference

31 March 2020

1 reference

31 March 2020

1 reference

Scientific and ethical issues in equivalence trials

31 March 2020

1 reference

When placebo controlled trials are essential and equivalence trials are inadequate

31 March 2020

1 reference

How children can be respected as 'ends' yet still be used as subjects in non-therapeutic research

31 March 2020

1 reference

Do healthy children deserve greater protection in medical research?

31 March 2020

1 reference

Assessment of risk in research on children

31 March 2020

1 reference

Moral problems in assessing research risk.

31 March 2020

1 reference

Moral solutions in assessing research risk.

31 March 2020

1 reference

In loco parentis. Minimal risk as an ethical threshold for research upon children

31 March 2020

1 reference

Equipoise and the ethics of clinical research

31 March 2020

1 reference

Nonbeneficial research with individuals who cannot consent: is it ethically better to enroll healthy or affected individuals?

31 March 2020

1 reference

Ethical principles in federal regulations: the case of children and research risks

31 March 2020

1 reference

The ethics of paying for children's participation in research.

31 March 2020

1 reference

What's the price of a research subject? Approaches to payment for research participation.

31 March 2020

1 reference

Paying for children to participate in research: a slippery slope or an enlightened stairway?

31 March 2020

1 reference